si
The New York Mets made their first notable offseason acquisition on Friday, bringing back right-handed pitcher Robert Stock on a one-year major-league deal. The 36-year-old veteran had a brief stint with the club in the second half of last season, making a handful of appearances.
This move appears to be a strategic effort by the Mets to inject veteran leadership into a rotation that features three promising young starters: Nolan McLean, Christian Scott, and Zac Thornton. While the Mets clearly need to upgrade a pitching staff that struggled again last year, the question remains: what grade does this signing deserve?
Stock's statistics from last season are underwhelming: in eight games (seven starts), he recorded a 5.93 ERA over 30.1 innings. Those numbers alone justify a grade of C+. Additionally, Stock missed the first five months of the year after undergoing thoracic outlet surgery, and his health remains a significant concern heading into the 2027 season.
However, there are encouraging signs. In his seven starts, Stock allowed one or zero earned runs and pitched at least four innings four times. His best outing came on August 31 against the eventual AL champion Tampa Bay Rays, when he tossed a season-high 5.1 innings, allowing no earned runs on five hits while striking out four.
Stock also performed well in high-pressure situations, holding opponents to a .133 average and .435 OPS with runners in scoring position and two outs. That trait is crucial for a pitcher likely to work out of the bullpen. Furthermore, he limited hard contact, posting a 36.4 hard-hit rate.
Despite not pitching deep into games last season, Stock can serve as a long reliever in what is currently a questionable Mets bullpen. It may not be the splashy move fans were hoping for, but it could prove to be a low-risk, high-reward addition given Stock's veteran experience and New York's need for pitching depth.
Key Analysis
The Mets' decision to re-sign Robert Stock reflects a pragmatic approach to building pitching depth. While Stock's overall numbers are not impressive, his ability to limit damage with runners in scoring position and induce soft contact suggests he can be a useful bullpen piece. The low-risk nature of the deal—a one-year major-league contract—makes it a sensible move for a team that needs to bolster its pitching staff without committing significant resources. However, Stock's health history and age are red flags that could limit his effectiveness. Ultimately, this signing earns a C+ grade: it addresses a need but comes with considerable uncertainty.